BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 8, 2026
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
July 7, 2010
View Archived Issues
Study Reveals a Dozen New Diabetes Genes to Explore
Read More
Galapagos Enters $374M Osteoarthritis Pact with Servier
Read More
Swedish Orphan Biovitrum Eyes Manchurian Drug Candidates
Read More
Corrections & Clarifications
Read More
Postive Results Reported for NovaBiotics' Fungal Therapy
Read More
Other News To Note
Read More
Intercell's Adjuvant Patch Fails to Boost Pandemic Flu Vaccine
A faulty hemagglutinin inhibition assay may be the reason underlying the failure of a Phase II clinical trial of Intercell AG's investigational Vaccine Enhancement Patch (VEP) for H5N1 influenza. (BioWorld International)
Read More
Germany Funds Biobank Targeting Chronic Diseases
Read More
